Mesoporous silica-based versatile theranostic nanoplatform constructed by layer-by-layer assembly for excellent photodynamic/chemo therapy

Biomaterials

Volumn 117, Issue , 2017, Pages 54-65

  Chen, Wei Hai ^a   Luo, Guo Feng ^a   Qiu, Wen Xiu ^a   Lei, Qi ^a   Liu, Li Han ^a   Wang, Shi Bo ^a   Zhang, Xian Zheng ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Dual modal imaging; Mesoporous silica nanoparticle; Photodynamic chemo therapy; Supramolecular photosensitizer; Tumor target

Indexed keywords

CHEMOTHERAPY; MESOPOROUS MATERIALS; NANOPARTICLES; PHOTOSENSITIZERS; SILICA; SUPRAMOLECULAR CHEMISTRY; TUMORS;

DUAL-MODAL IMAGING; HOST GUEST INTERACTIONS; LAYER-BY-LAYER ASSEMBLIES; MESOPOROUS SILICA NANOPARTICLES; PHOTODYNAMIC THERAPY (PDT); PHOTODYNAMIC/CHEMO THERAPY; TUMOR PROGRESSIONS; TUMOR TARGETS;

PHOTODYNAMIC THERAPY;

MESOPOROUS SILICA NANOPARTICLE; MOLECULAR LAYER; PHOTOSENSITIZING AGENT; TIRAPAZAMINE; ANTINEOPLASTIC AGENT; NANOCAPSULE; SILICON DIOXIDE; TRIAZINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL VIABILITY; CHELATION; CLICK CHEMISTRY; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; STATIC ELECTRICITY; SUPRAMOLECULAR CHEMISTRY; SURFACE CHARGE; THERANOSTIC NANOMEDICINE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; CHLOROCEBUS AETHIOPS; CRYSTALLIZATION; CV-1 CELL LINE; DIAGNOSTIC IMAGING; EXPERIMENTAL NEOPLASM; FEMALE; FLUORESCENCE MICROSCOPY; MCF-7 CELL LINE; NANOPORE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PHOTOCHEMOTHERAPY; PROCEDURES; THREE DIMENSIONAL PRINTING; TREATMENT OUTCOME; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CERCOPITHECUS AETHIOPS; COS CELLS; CRYSTALLIZATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NANOCAPSULES; NANOPORES; NEOPLASMS, EXPERIMENTAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRINTING, THREE-DIMENSIONAL; SILICON DIOXIDE; THERANOSTIC NANOMEDICINE; TREATMENT OUTCOME; TRIAZINES;

EID: 85000977755     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.11.057     Document Type: Article

References (40)

1. [1] Celli, J.P., Spring, B.Q., Rizvi, I., Evans, C.L., Samkoe, K.S., Verma, S., et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem. Rev. 110 (2010), 2795–2838.
2. [2] Dolmans, D.E., Fukumura, D., Jain, R.K., Photodynamic therapy for cancer. Nat. Rev. Cancer 3 (2003), 380–387.
3. [3] Hu, Y., Yang, Y., Wang, H., Du, H., Synergistic integration of layer-by-layer assembly of photosensitizer and gold nanorings for enhanced photodynamic therapy in the near infrared. ACS Nano 9 (2015), 8744–8754.
4. [4] Voskuhl, J., Kauscher, U., Gruener, M., Frisch, H., Wibbeling, B., Strassert, C.A., et al. A soft supramolecular carrier with enhanced singlet oxygen photosensitizing properties. Soft Matter 9 (2013), 2453–2457.
5. [5] Roy, I., Ohulchanskyy, T.Y., Pudavar, H.E., Bergey, E.J., Oseroff, A.R., Morgan, J., et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J. Am. Chem. Soc. 125 (2003), 7860–7865.
6. [6] Konan, Y.N., Gurny, R., Allémann, E., State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem Photobiol. B 66 (2002), 89–106.
7. [7] Singh, S., Aggarwal, A., Bhupathiraju, N.V., Arianna, G., Tiwari, K., Drain, C.M., Glycosylated porphyrins, phthalocyanines, and other porphyrinoids for diagnostics and therapeutics. Chem. Rev. 115 (2015), 10261–10306.
8. [8] Oar, M.A., Serin, J.M., Dichtel, W.R., Fréchet, J.M.J., Photosensitization of singlet oxygen via two-photon-excited fluorescence resonance energy transfer in a water-soluble dendrimer. Chem. Mater. 17 (2005), 2267–2275.
9. [9] Lucky, S.S., Soo, K.C., Zhang, Y., Nanoparticles in photodynamic therapy. Chem. Rev. 115 (2015), 1990–2042.
10. [10] Chatterjee, D.K., Fong, L.S., Zhang, Y., Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug Deliv. Rev. 60 (2008), 1627–1637.
11. [11] Lu, K., He, C., Lin, W., A chlorin-based nanoscale metal-organic framework for photodynamic therapy of colon cancers. J. Am. Chem. Soc. 137 (2015), 7600–7603.
12. [12] Huang, P., Lin, J., Wang, X., Wang, Z., Zhang, C., He, M., et al. Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv. Mater. 24 (2012), 5104–5110.
13. [13] Bai, H., Yuan, H., Nie, C., Wang, B., Lv, F., Liu, L., et al. A supramolecular antibiotic switch for antibacterial regulation. Angew. Chem. Int. Ed. Engl. 54 (2015), 13208–13213.
14. [14] Liang, R., Tian, R., Ma, L., Zhang, L., Hu, Y., Wang, J., et al. A supermolecular photosensitizer with excellent anticancer performance in photodynamic therapy. Adv. Funct. Mater. 24 (2014), 3144–3151.
15. [15] Liu, K., Liu, Y., Yao, Y., Yuan, H., Wang, S., Wang, Z., et al. Supramolecular photosensitizers with enhanced antibacterial efficiency. Angew. Chem. Int. Ed. Engl. 52 (2013), 8285–8289.
16. [16] Kitagishi, H., Chai, F., Negi, S., Sugiura, Y., Kano, K., Supramolecular intracellular delivery of an anionic porphyrin by octaarginine-conjugated per-O-methyl-β-cyclodextrin. Chem. Commun. 51 (2015), 2421–2424.
17. [17] Bonchio, M., Carofiglio, T., Carraro, M., Fornasier, R., Tonellato, U., Efficient sensitized photooxygenation in water by a porphyrin-cyclodextrin supramolecular complex. Org. Lett. 4 (2002), 4635–4637.
18. [18] Luo, G.F., Chen, W.H., Lei, Q., Qiu, W.X., Liu, Y.X., Cheng, Y.J., et al. A triple-collaborative strategy for high-performance tumor therapy by multifunctional mesoporous silica-coated gold nanorods. Adv. Funct. Mater. 26 (2016), 4339–4350.
19. [19] Kim, J., Santos, O.A., Park, J.H., Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy. J. Control Release 191 (2014), 98–104.
20. [20] Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2 (2007), 751–760.
21. [21] Veiseh, O., Gunn, J.W., Zhang, M., Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 62 (2010), 284–304.
22. [22] Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat. Rev. Drug Discov. 201;13:813–827.
23. [23] Henderson, B.W., Fingar, V.H., Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 47 (1987), 3110–3114.
24. [24] Fan, H., Yan, G., Zhao, Z., Hu, X., Zhang, W., Liu, H., et al. A smart photosensitizer-manganese dioxide nanosystem for enhanced photodynamic therapy by reducing glutathione levels in cancer cells. Angew. Chem. Int. Ed. Engl. 55 (2016), 5477–5482.
25. [25] Jin, C.S., Lovell, J.F., Chen, J., Zheng, G., Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly. ACS Nano 7 (2013), 2541–2550.
26. [26] Liu, Y., Liu, Y., Bu, W., Cheng, C., Zuo, C., Xiao, Q., et al. Hypoxia induced by upconversion-based photodynamic therapy: towards highly effective synergistic bioreductive therapy in tumors. Angew. Chem. Int. Ed. Engl. 54 (2015), 8105–8109.
27. [27] Brown, J.M., Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol. Med. Today 6 (2000), 157–162.
28. [28] Kim, J.S., Rieter, W.J., Taylor, K.M., An, H., Lin, W., Lin, W., Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging. J. Am. Chem. Soc. 129 (2007), 8962–8963.
29. [29] Cheng, L., Gong, H., Zhu, W., Liu, J., Wang, X., Liu, G., et al. PEGylated prussian blue nanocubes as a theranostic agent for simultaneous cancer imaging and photothermal therapy. Biomaterials 35 (2014), 9844–9852.
30. [30] Yan, Y., Such, G.K., Johnston, A.P., Lomas, H., Caruso, F., Toward therapeutic delivery with layer-by-layer engineered particles. ACS Nano 5 (2011), 4252–4257.
31. [31] Yoon, H.Y., Koo, H., Choi, K.Y., Lee, S.J., Kim, K., Kwon, I.C., et al. Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials 33 (2012), 3980–3989.
32. [32] Sun, Q., Kang, Z., Xue, L., Shang, Y., Su, Z., Sun, H., et al. A collaborative assembly strategy for tumor-targeted siRNA delivery. J. Am. Chem. Soc. 137 (2015), 6000–6010.
33. [33] Chen, W.H., Luo, G.F., Qiu, W.X., Lei, Q., Hong, S., Wang, S.B., et al. Programmed nanococktail for intracellular cascade reaction regulating self-synergistic tumor targeting therapy. Small 12 (2016), 733–744.
34. [34] Hu, Q., Sun, W., Lu, Y., Bomba, H.N., Ye, Y., Jiang, T., et al. Tumor microenvironment-mediated construction and deconstruction of extracellular drug-delivery depots. Nano Lett. 16 (2016), 1118–1126.
35. [35] Choi, K.Y., Yoon, H.Y., Kim, J.H., Bae, S.M., Park, R.W., Kang, Y.M., et al. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano 5 (2011), 8591–8599.
36. [36] Mo, R., Jiang, T., DiSanto, R., Tai, W., Gu, Z., ATP-triggered anticancer drug delivery. Nat. Commun. 5 (2014), 3364–3373.
37. [37] Pan, L., He, Q., Liu, J., Chen, Y., Ma, M., Zhang, L., et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J. Am. Chem. Soc. 134 (2012), 5722–5725.
38. [38] Wang, T., Wang, D., Yu, H., Wang, M., Liu, J., Feng, B., et al. Intracellularly acid-switchable multifunctional micelles for combinational photo/chemotherapy of the drug-resistant tumor. ACS Nano 10 (2016), 3496–3508.
39. [39] Tang, L., Yang, X., Yin, Q., Cai, K., Wang, H., Chaudhury, I., et al. Investigating the optimal size of anticancer nanomedicine. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 15344–15349.
40. [40] Verwilst, P., Park, S., Yoon, B., Kim, J.S., Recent advances in Gd-chelate based bimodal optical/MRI contrast agents. Chem. Soc. Rev. 44 (2015), 1791–1806.